{"prompt": "['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', 'Clinical Study Protocol', 'Protocol Title:', 'A Prospective, Multi-center, Randomized, Clinical Trial Evaluating the Safety', 'and Effectiveness of Using COOLIEF TM Cooled Radiofrequency Probe to', 'Create Lesions of the Genicular Nerves and Comparing a Single Injection of', 'Hyaluronic Acid in the Management of Knee Pain.', 'Protocol #:', '105-17-0001', 'Study Short Name:', 'Genicular Nerve Lesion Study', 'Test Article(s):', 'Treatment Group: COOLIEFTM Cooled Radiofrequency Probe (CRFA)', 'Control Group: Synvisc-One (HA)', 'Regulatory', 'Class II Medical Device: Probe (cleared under K053082) used in conjunction', 'Classification:', 'with radiofrequency generator (cleared under K072478). Specific clearance', 'for use for osteoarthritis (OA) knee pain under K163461', 'Study Phase:', 'Pivotal', 'Indications:', 'Pain Management; Osteoarthritis of the knee; RF Ablation', 'Sponsor:', 'Avanos Medical', '5405 Windward Parkway', 'Alpharetta, GA 30004', 'Study Director:', 'David Curd, MS', '5405 Windward Parkway', 'Alpharetta, GA 30004', 'Medical Monitor:', 'Dr. Hilton Kaplan, MBBCh FCSSA PhD', '5405 Windward Parkway, Alpharetta, GA 30004', 'Lead Principal', 'Antonia F. Chen, MD/MBA', 'Investigator', 'Current Protocol', 'Version:', 'Version 4.0 (dated 28Mar2019)', 'Version 3.0 (dated 8Feb2018)', 'Previous Protocol', 'Versions:', 'Version 2.0 (dated 06Dec2017)', 'Version 1.0 (dated 20Sep2017)', 'The study will be conducted in compliance with this protocol and the following applicable regulations', '&', 'Good Clinical Practices (GCPs):', '21CFR 11', '21 CFR 50', '21 CFR 54', '21 CFR 56', '21 CFR 812.2 (b)', 'Version #: 4.0', 'Page 1 of 62', 'Version Date: 28Mar19']['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', '1', 'GENERAL INFORMATION', 'This study is being performed to assess the relative effectiveness of the COOLIEF TM Pain Management', 'System (formerly owned by Halyard Health, and now owned by Avanos Medical; Alpharetta GA) to', 'manage moderate to severe knee pain in patients with osteoarthritis (OA) of the knee when compared to', 'a single Viscosupplementation injection. The product under study is currently marketed in the United', 'States and has been cleared via 510(k) by the FDA under application K053082 and K163461 in', 'combination with the Halyard Radiofrequency (RF) Generator (PMG-115-TD/PMG-230-TD, or PMG-', 'BASIC/PMG-ADVANCED K072478) for use in creating radiofrequency lesions in nervous tissue. It is also', 'indicated for creating radiofrequency lesions of the genicular nerves for the management of moderate to', 'severe knee pain of more than 6 months with conservative therapy, including medication, in patients with', 'radiographically-confirmed osteoarthritis (grade 2-4) and a positive response (= 50% reduction in pain) to', 'a diagnostic genicular nerve block.', 'A Long-Term Extension will capture data allowing the assessment of the long term clinical outcomes', '(such as current level of pain, function, and progression of disease) for patients who received COOLIEF*', 'as their initial treatment. Subjects who received COOLIEF* as their initial treatment will be asked to return', 'for 2 additional visits representing 18 and 24 months post initial treatment.', 'Version #: 4.0', 'Page 2 of 62', 'Version Date: 28Mar19']['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', 'Investigator Acknowledgement Signature Page', 'Title: A Prospective, Multi-center, Randomized, Clinical Trial Evaluating the Safety and', 'Effectiveness of Using COOLIEF TM Cooled Radiofrequency Probe to Create Lesions of the', 'Genicular Nerves and Comparing a Single Injection of Hyaluronic Acid in the Management of Knee', 'Pain', 'I have read the attached protocol and agree that it contains all the necessary details for performing the', 'study. I agree to conduct the study according to the protocol.', 'I will provide copies of the protocol and of the pre-clinical information on the Study Device (e.g.,', 'Investigator Brochure or Report of Prior Investigations) that was furnished to me by the Sponsor to all', 'members of the study team responsible to me. I will discuss this material with them to assure that they', 'are fully informed regarding the Study Device and the conduct of the study.', 'Once the protocol has been approved by the IRB/IEC, I will not modify this protocol without obtaining the', 'prior approval of the Sponsor and of the IRB/IEC. I will submit all protocol modifications and/or any', 'informed consent modifications to the Sponsor and the IRB /IEC, and approval will be obtained before', 'any modifications are implemented. I will also submit all Serious Adverse Events and Protocol Violations', 'to the IRB/IEC per their requirements.', 'Investigator Printed Name', 'Signature', 'Date', 'Version #: 4.0', 'Page 3 of 62', 'Version Date: 28Mar19']\n\n###\n\n", "completion": "END"}